The rapid growth of GLP-1 weight loss treatments across Asia is starting to reshape how consumers approach food, health and long-term wellbeing. In a recent feature with FoodNavigator, our Commercial Director Amy Stobie shared her perspective on what this shift means for food and drink brands.
In the article, Amy highlights how markets such as China are well positioned for this change, with an established focus on sustained weight management rather than short-term fixes. As she explains, “China’s health messaging has long framed obesity as a chronic disease, which has educated the population on the need to take a sustained approach to weight management.”
She also explores how GLP-1 treatments fit within a broader lifestyle approach. Rather than acting as a standalone solution, they are most effective when combined with lasting behavioural change. As the piece notes, “GLP-1 agonists could therefore serve as the catalyst for weight loss before those crucial lifestyle changes kick in.”
For brands, this signals a clear shift. As consumers become more health-conscious and intentional, there is a growing need to rethink how products, messaging and overall positioning support long-term wellbeing.
Click here to see the full article on our website
Every day we apply our strategic, creative and technical expertise to create a meaningful difference for our client’s brands. We help them reach their goals by directing their brands to become smarter, more desirable and more valuable.
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information
